Sam Altman's longevity startup is testing a pill for a younger brain
✦
✦
✦
AI is analyzing the discussion...
Topic starter
Translate
â–¼
English
Spanish
French
German
Italian
Portuguese
Russian
Chinese
Japanese
Korean
Arabic
Hindi
Dutch
Polish
Turkish
Vietnamese
Thai
Swedish
Danish
Finnish
Norwegian
Czech
Hungarian
Romanian
Greek
Hebrew
Indonesian
Malay
Ukrainian
Bulgarian
Croatian
Slovak
Slovenian
Serbian
Lithuanian
Latvian
Estonian
Show original
Translating...
Sep 18, 2025 9:16 pm
(@Dr. Young)
Joined: 10 months ago
Retro Biosciences is a longevity startup backed by OpenAI's CEO, Sam Altman.
Retro's said its first human clinical trial is set to launch by the end of 2025.
It's for a pill designed to clear out "gunk" in the brain and reverse Alzheimer's.
https://www.businessinsider.com/retro-biosciences-sam-altman-antiaging-brain-pill-longevity-healthspan-2025-9
Subscribe to this topic
Reply
Cancel
Preview
0 Revisions
Save Draft
Saved